Consequences of meconium stained amniotic fluid: What does the evidence tell us?

详细信息    查看全文

• 作者：Eileen K. Hutton^a ; ^b ; ^c ; ^{huttone@mcmaster.ca" class="auth_mail} ; Julia Thorpe^c ; ¹ ; ^{jthorpe@mcmaster.ca" class="auth_mail}
• 关键词：Meconium ; Meconium stained amniotic fluid ; Evidence-based consequences
• 刊名：Early Human Development
• 出版年：July 2014
• 年：2014
• 卷：90
• 期：7
• 页码：333-339
• 全文大小：288 K

文摘

Meconium stained amniotic fluid (MSAF) is common and associated with meconium aspiration syndrome (MAS). Other consequences of meconium passage before birth are less well understood.

Methods

We reviewed the literature for original papers reporting on outcomes associated with MSAF.

Findings

Among preterm infants MSAF is more prevalent than previously believed and is associated with higher neonatal morbidity. Intrauterine exposure to meconium is associated with inflammation of tissues of the lung, chorionic plate and umbilical vessels and through various mechanisms may contribute to neonatal morbidity, independent of MAS. No compelling evidence supported an association between MSAF and increased neurological impairment, including early seizure activity.